Table 1.
Patients demographics.
| Type of stent | PCSEMS | FCSEMS with fins | FCSEMS with flare ends |
|---|---|---|---|
| N | 3 | 18 | 10 |
|
| |||
| Gender | |||
| Male | 3 | 15 | 7 |
|
| |||
| Age | |||
| (mean ± SD) | 50 ± 8.7 | 53.9 ± 5.0 | 56 ± 6.7 |
| Median (range) | 40–56 | 42–60 | 48–69 |
|
| |||
| Underlying liver disease | |||
| HCV | 6 | 4 | |
| Ethanol | 3 | 1 | |
| Cryptogenic | 2 | 3 | 2 |
| HCV + ethanol | 2 | 2 | |
| HBV | 1 | ||
| NASH | 1 | 1 | 1 |
| Other | 2 | ||
|
| |||
| Post-OLT leak location | |||
| Anastomotic | 1 (33.3%) | 14 (77.8%) | 7 (70%) |
| Nonanastomotic | 2 (66.7%) | 4 (22.2%) | 3 (30%) |
|
| |||
| Time OLT to procedure (days) | |||
| Mean (SD) | 36 (±8) | 53.2 (±85.8) | 22.9 (±16.4) |
| Median (range) | 33 (29–45) | 20 (6–328) | 19 (5–63) |
|
| |||
| Previous plastic stenting | |||
| Yes | 100% | 3 (16.7%) | 2 (20%) |
| T-tube | 0 | 0 | 1 (10%) |
OLT: orthotopic liver transplant, SD: standard deviation, HCV: hepatitis C virus; HBC: hepatitis B virus; others (hemochromatosis, alpha-1-antitrypsin). PCSEMS: partially covered self-expanding metal stent, FCSEMS: fully covered self-expanding metal stent.